<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Nationwide Classes OK&#8217;d In Wholesale Pricing Case</title>
	<atom:link href="http://www.pharmalot.com/2008/10/nationwide-classes-okd-in-wholesale-pricing-case/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/10/nationwide-classes-okd-in-wholesale-pricing-case/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 21:06:34 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Mr Wholesale Dropship</title>
		<link>http://www.pharmalot.com/2008/10/nationwide-classes-okd-in-wholesale-pricing-case/#comment-387072</link>
		<dc:creator>Mr Wholesale Dropship</dc:creator>
		<pubDate>Sat, 17 Jan 2009 11:45:56 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=16123#comment-387072</guid>
		<description>The first class includes third-party payors who made reimbursements for Medicare Part B covered drugs based on average wholesale prices. The second class includes consumer or third-party payors who paid for certain physician-administered drugs made by AstraZeneca or Bristol-Myers.</description>
		<content:encoded><![CDATA[<p>The first class includes third-party payors who made reimbursements for Medicare Part B covered drugs based on average wholesale prices. The second class includes consumer or third-party payors who paid for certain physician-administered drugs made by AstraZeneca or Bristol-Myers.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.145 seconds -->

